List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially. List price is not what anyone pays.
27 likes 4mo
Topic summary
List price versus negotiated price versus what you pay
This is a generated summary. It shows the 9 most-liked posts from a topic of 116, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
Coming back to post #26, because the follow-up matters more than the original answer.
International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US prices are higher than other developed nations.
29 likes 4mo
I disagree with the reply above, and I think the disagreement is substantive rather than terminological.
The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.
28 likes 4mo
This follows post #46 rather than contradicting it.
Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
32 likes 4mo
post #77 answers the question as asked. The question underneath it is different.
For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
32 likes 3mo
I disagree with the reply above, and I think the disagreement is substantive rather than terminological.
The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.
31 likes 3mo
c.adebayo, post #5: Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers and manufacturers. Go to post
Worth separating two things that post #108 runs together.
Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be compared on price per milligram alone because dead volume, wastage, and number of doses actually obtainable differ.
Read the full topic (116 posts)
This topic was referenced in
- Cost per delivered dose, which is the number that mattersAccess › Pricing · 59 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Cost per milligram, computed honestly across formats — the long version
Cost per milligram, computed honestly across formats — the long version Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail…
|
+111 | 124 | 24k | 14mo |
|
Cost per milligram, computed honestly across formats
Posting this under the heading it deserves: Cost per milligram, computed honestly across formats Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this…
|
2 | 47k | 18mo | |
|
Revisiting: List price versus negotiated price versus what you pay
Revisiting: List price versus negotiated price versus what you pay — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is…
|
+24 | 28 | 50k | 12mo |
|
Pen wastage and its effect on real cost — the long version
Posting this under the heading it deserves: Pen wastage and its effect on real cost — the long version Everything below is what sits behind that. Documenting an access outcome, dated, because everything in…
|
2 | 34k | 13mo | |
|
Manufacturer assistance programmes and their eligibility rules
On the subject in the title: Manufacturer assistance programmes and their eligibility rules Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…
|
+37 | 42 | 32k | 11d |
Related topics — sharing the tags formulary, data table, compounding
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Oxidation pathways for methionine and tryptophan
Posting this under the heading it deserves: Oxidation pathways for methionine and tryptophan Everything below is what sits behind that. Working through the identity arithmetic and I would like it checked.…
|
+58 | 63 | 1k | 19mo |
|
What a reversed-phase purity number actually is
The question in the title: What a reversed-phase purity number actually is I will give what I have already checked below so nobody repeats it. I would like to understand what this number means before I repeat…
|
+87 | 101 | 27k | 4h |
|
How shortages have affected compounding permissions
How shortages have affected compounding permissions I have a specific reason for asking rather than idle curiosity, and the context is below. A coverage question with the paperwork detail included, since that…
|
+61 | 71 | 3.6k | 2d |
|
Ultrasound and skinfolds: operator dependence in practice — what changed since
Posting this under the heading it deserves: Ultrasound and skinfolds: operator dependence in practice — what changed since Everything below is what sits behind that. Longitudinal report with the method…
|
+32 | 37 | 7.4k | 3mo |
|
Aggregated purity results across four services, with caveats
Posting this under the heading it deserves: Aggregated purity results across four services, with caveats Everything below is what sits behind that. Working through the identity arithmetic and I would like it…
|
3 | 24k | 9mo |